Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1990 | 12-1989 | 03-1989 | 12-1988 | 03-1988 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,301 | 10,312 | 5,301 | 5,301 | N/A |
| Other current assets | 73 | 71 | 73 | 73 | 0 |
| TOTAL | $5,374 | $10,383 | $5,374 | $5,374 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,737 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 130 | 233 | 130 | 130 | 0 |
| TOTAL | $2,867 | $233 | $130 | $130 | $N/A |
| Total Assets | $7,428 | $12,498 | $7,428 | $7,428 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 142 | 342 | 142 | 142 | 0 |
| Accrued Expenses | 344 | 471 | 344 | 344 | N/A |
| Other current liabilities | 0 | 667 | 0 | 0 | N/A |
| TOTAL | $745 | $1,808 | $745 | $745 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $282 | $481 | $282 | $282 | $N/A |
| Total Liabilities | $1,027 | $2,289 | $1,027 | $1,027 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 2 | 2 | 2 | 2 | N/A |
| Retained earnings | -5,711 | -9,754 | -5,711 | -5,711 | N/A |
| Other shareholders' equity | 12,064 | 19,913 | 12,064 | 12,064 | 0 |
| TOTAL | $6,402 | $10,209 | $6,402 | $6,402 | $N/A |
| Total Liabilities And Equity | $7,428 | $12,498 | $7,428 | $7,428 | $0 |